Beijing Tiantan Biological Products Corp Ltd (600161) — Cash Flow Reinvestment Rate
Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥125.07 Million (capex CN¥125.07 Million ) from operating cash flow of CN¥318.80 Million. See 600161 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Tiantan Biological Products Corp Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. For the full cash flow conversion analysis, see Beijing Tiantan Biological Products Corp (600161) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year capital reinvestment analysis for Beijing Tiantan Biological Products Corp Ltd. See 600161 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.36x | CN¥1.11 Billion | CN¥819.78 Million | CN¥1.07 Billion | ▲ +29.8% |
| 2023 | 1.05x | CN¥2.51 Billion | CN¥2.39 Billion | CN¥1.08 Billion | ▼ -63.4% |
| 2022 | 2.86x | CN¥3.22 Billion | CN¥1.13 Billion | CN¥1.35 Billion | ▲ +29.9% |
| 2021 | 2.21x | CN¥2.16 Billion | CN¥980.35 Million | CN¥1.13 Billion | ▲ +149.7% |
| 2020 | 0.88x | CN¥619.92 Million | CN¥702.11 Million | CN¥608.91 Million | ▲ +2.9% |
| 2019 | 0.86x | CN¥551.23 Million | CN¥642.47 Million | CN¥526.23 Million | ▲ +79.6% |
| 2018 | 0.48x | CN¥323.90 Million | CN¥677.92 Million | CN¥293.90 Million | ▼ -39.6% |
| 2017 | 0.79x | CN¥172.87 Million | CN¥218.39 Million | CN¥144.87 Million | ▲ +42.8% |
| 2016 | 0.55x | CN¥237.39 Million | CN¥428.37 Million | CN¥209.39 Million | ▼ -20.2% |
| 2015 | 0.69x | CN¥328.57 Million | CN¥473.26 Million | CN¥300.57 Million | ▼ -28.5% |
| 2014 | 0.97x | CN¥464.16 Million | CN¥477.95 Million | CN¥464.16 Million | ▲ +0.3% |
| 2013 | 0.97x | CN¥548.37 Million | CN¥566.43 Million | CN¥548.37 Million | ▼ -25.0% |
| 2012 | 1.29x | CN¥557.87 Million | CN¥432.00 Million | CN¥557.87 Million | ▼ -36.5% |
| 2011 | 2.04x | CN¥718.67 Million | CN¥353.15 Million | CN¥718.67 Million | ▲ +26.4% |
| 2010 | 1.61x | CN¥297.54 Million | CN¥184.85 Million | CN¥297.54 Million | ▲ +277.4% |
| 2009 | 0.43x | CN¥191.17 Million | CN¥448.23 Million | CN¥191.17 Million | ▼ -21.6% |
| 2008 | 0.54x | CN¥150.31 Million | CN¥276.39 Million | CN¥150.31 Million | ▲ +25.8% |
| 2007 | 0.43x | CN¥66.40 Million | CN¥153.55 Million | CN¥66.40 Million | ▼ -6.6% |
| 2006 | 0.46x | CN¥71.50 Million | CN¥154.36 Million | CN¥71.50 Million | ▲ +53.3% |
| 2005 | 0.30x | CN¥39.78 Million | CN¥131.69 Million | CN¥39.78 Million | ▼ -61.3% |
| 2004 | 0.78x | CN¥85.89 Million | CN¥110.11 Million | CN¥85.89 Million | ▼ -45.5% |
| 2003 | 1.43x | CN¥90.02 Million | CN¥62.93 Million | CN¥90.02 Million | ▲ +246.6% |
| 2002 | 0.41x | CN¥34.83 Million | CN¥84.38 Million | CN¥34.83 Million | ▼ -60.9% |
| 2001 | 1.06x | CN¥49.09 Million | CN¥46.49 Million | CN¥49.09 Million | ▲ +14.9% |
| 2000 | 0.92x | CN¥44.04 Million | CN¥47.90 Million | CN¥44.04 Million | ▼ -9.7% |
| 1999 | 1.02x | CN¥43.34 Million | CN¥42.58 Million | CN¥43.34 Million | ▼ -58.1% |
| 1998 | 2.43x | CN¥57.61 Million | CN¥23.71 Million | CN¥57.61 Million | — |